Beth Erickson, MD, FACR, FASTRO, FABS, discussed pioneering MRI-guided brachytherapy at MCW and her priorities as incoming ASTRO president-elect.
|Videos|September 29, 2017
ASTRO 2017: Aggressive Therapy Fails in High-Risk Endometrial Cancer
Author(s)Marcus Randall, MD
This video reviews results of a phase III trial that compared pelvic radiation therapy vs vaginal cuff brachytherapy plus chemotherapy in patients with early-stage, high-risk endometrial cancer.
Advertisement
In this video, Marcus Randall, MD, of the University of Kentucky College of Medicine, discusses a phase III Gynecologic Oncology Group (GOG) trial that compared pelvic radiation therapy vs vaginal cuff brachytherapy plus paclitaxel/carboplatin in patients with early-stage, high-risk endometrial cancer.
Randall presented results of the study (
Advertisement
Related to this article
Advertisement
Advertisement
Trending on CancerNetwork
1
BCMA/GPRC5D CAR T-Cell Therapy Shows Early Efficacy in R/R Multiple Myeloma
2
Multimodal Biopsy Combo Shows Low Morbidity in Suspected Prostate Cancer
3
Integrating Talazoparib Plus Enzalutamide Into HRR-Mutated mHSPC Care
4
Aglatimagene Combo Shows Sustained Immune Remodeling in Prostate Cancer
5